Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220012970 220007421 1.92 101.7 null 2017-07-20 2017-07-24 Trial Unspecified 01 null 220028665 TRIAL
220012971 220007422 1.69 61 Curative (C) 2014-10-15 2014-11-02 Trial Unspecified Y N 220028667 TRIAL
220012972 220017682 null 90 Palliative (P) null 2013-05-13 AML 19 TRIAL Y null 220028677 AML19 TRIAL
220012973 220017682 null 68.2 Adjuvant (A) 2016-04-15 2016-04-15 AML 19 TRIAL null null 220028677 AML19 TRIAL
220012974 220017683 1.66 52.8 Curative (C) 2017-01-06 2017-02-06 AML 19 TRIAL N N 220028683 AML19 TRIAL
220012975 220007424 1.68 null Curative (C) null 2014-01-10 Trial Unspecified 01 N 220028683 TRIAL
220012976 220007426 1.69 66.2 Curative (C) 2016-08-29 2016-09-03 Trial Unspecified N N 220028687 TRIAL
220012977 220014091 1.75 100.7 Curative (C) null 2015-08-20 AML 19 TRIAL 01 N 220028687 AML19 TRIAL
220012978 220007427 1.68 94.5 Curative (C) 2015-05-07 2015-08-15 AML 19 TRIAL N N 220028704 AML19 TRIAL
220012979 220007428 1.72 85.4 Curative (C) 2017-02-15 2017-02-15 AML 19 TRIAL 01 N 220028704 AML19 TRIAL
220012980 220007429 1.84 84 Curative (C) 2014-04-30 2014-07-14 AML 19 TRIAL Y N 220028709 AML19 TRIAL
220012981 220007432 1.58 121.4 Curative (C) 2014-05-08 2014-05-08 Trial Unspecified 01 N 220028709 TRIAL
220012982 220007434 1.72 76.9 Curative (C) 2013-06-22 2013-06-24 Trial Unspecified Y N 220028724 TRIAL
220012983 220007435 1.8 54 Curative (C) null 2016-09-16 Trial Unspecified Y N 220028725 TRIAL
220012987 220021515 1.63 64.4 Curative (C) 2014-12-05 2015-01-26 AML 19 TRIAL N N 220028735 AML19 TRIAL
220012988 220021515 1.63 71 Curative (C) 2017-07-18 2017-07-19 AML 19 TRIAL N N 220028735 AML19 TRIAL
220012989 220007438 1.78 63.8 Curative (C) 2014-06-01 2014-06-03 Trial Unspecified Y N 220028743 TRIAL
220012990 220007439 1.6 null Disease modification (D) 2018-01-16 2018-01-16 Trial Unspecified 2 N 220028760 TRIAL
220012991 220007440 1.85 60.8 Disease modification (D) 2017-04-05 2017-04-05 AML 19 TRIAL Y N 220028763 AML19 TRIAL
220012992 220007444 1.68 72.6 Adjuvant (A) 2014-12-22 2014-12-22 AML 19 TRIAL Y null 220028768 AML19 TRIAL
220012993 220007444 1.5 75.2 Disease modification (D) 2013-08-18 2013-08-22 Trial Unspecified 1 N 220028768 TRIAL
220012994 220007444 1.76 77.4 Curative (C) 2013-10-17 2013-10-23 AML 19 TRIAL 01 null 220028768 AML19 TRIAL
220012995 220007445 1.63 68.8 Curative (C) 2014-11-28 2014-12-02 Trial Unspecified Y N 220028779 TRIAL
220012996 220007445 1.7 128.4 Curative (C) null 2017-12-18 AML 19 TRIAL N N 220028779 AML19 TRIAL
220012997 220007445 1.56 71.8 Curative (C) 2016-02-07 2016-02-08 Trial Unspecified 01 N 220028779 TRIAL
220012998 220007446 null 84.8 Disease modification (D) 2014-06-12 2014-06-20 AML 19 TRIAL Y null 220028784 AML19 TRIAL
220013001 220007451 null 57.2 null 2017-02-21 2017-02-22 CYTARABINE N N 220028797 CYTARABINE
220013002 220017692 0 null Palliative (P) 2012-12-29 2013-01-22 Hydroxycarbamide N N 220028801 HYDROXYCARBAMIDE
220013003 220007453 0 null Palliative (P) 2016-07-11 2016-07-12 Hydroxycarbamide 2 N 220028802 HYDROXYCARBAMIDE
220013004 220007454 1.66 0 Palliative (P) 2013-06-22 2013-06-23 AML Interim Guidelines FLA -Ida N N 220028803 NOT MATCHED
220013005 220007456 null 64.9 Curative (C) 2017-06-03 2017-08-24 EZ 2 N 220028807 NOT MATCHED
220013006 220007458 1.78 98 Curative (C) null 2017-08-02 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE N N 220028807 NOT MATCHED
220013007 220007460 1.85 20.2 Curative (C) 2016-09-29 2016-09-29 null N N 220028814 NOT MATCHED
220013008 220007461 0 0 Palliative (P) 2015-08-04 2015-09-17 AML MyeChild N N 220028822 NOT MATCHED
220013009 220007461 1.6 41.8 Curative (C) 2014-10-05 2014-10-27 null null N 220028822 NOT MATCHED
220013010 220007463 0 15.85 Curative (C) 2017-04-24 2017-04-24 null null N 220028824 NOT MATCHED
220013011 220014109 1.57 46.2 Disease modification (D) 2015-09-15 2015-09-19 Hydroxycarbamide 02 N 220028829 HYDROXYCARBAMIDE
220013012 220014109 1.68 null null 2013-02-03 2013-02-03 Hydroxycarbamide N N 220028829 HYDROXYCARBAMIDE
220013013 220007464 1.65 63.3 Disease modification (D) 2018-01-18 2018-02-01 Hydroxycarbamide 2 null 220028832 HYDROXYCARBAMIDE
220013014 220007464 1.62 60 Disease modification (D) 2016-07-15 2016-07-15 Hydroxycarbamide 2 null 220028832 HYDROXYCARBAMIDE
220013015 220007464 1.7 89.1 Curative (C) 2016-06-20 2016-07-02 Hydroxycarbamide N N 220028832 HYDROXYCARBAMIDE
220013016 220007464 1.41 72.6 Curative (C) 2014-08-12 2015-05-18 FBC Conditionining N N 220028832 NOT MATCHED
220013017 220007464 0 51.5 Curative (C) 2016-09-24 2016-10-03 CYTARABINE 02 N 220028832 CYTARABINE
220013018 220007465 0.81 65 Curative (C) 2014-12-22 2014-12-28 CYTARABINE N N 220028859 CYTARABINE
220013019 220007466 1.74 54 Disease modification (D) 2014-07-17 2014-07-17 Hydroxycarbamide Y N 220028861 HYDROXYCARBAMIDE
220013020 220007468 null 25.55 Curative (C) 2015-10-26 2015-11-11 AML Interim Guidelines FLA -Ida N null 220028863 NOT MATCHED
220013021 220007470 1.8 64.7 Palliative (P) 2016-12-11 2017-02-20 Hydroxycarbamide 02 N 220028866 HYDROXYCARBAMIDE
220013022 220007470 0 null Curative (C) 2014-12-18 2014-12-19 CYTARABINE 2 N 220028866 CYTARABINE
220013023 220007471 0 84.1 null 2015-02-07 2015-02-10 Cytarabine low (10to20mg/m2) IV/SC N N 220028868 CYTARABINE
220013024 220007473 1.7 81.6 Curative (C) 2016-10-11 2016-11-28 CYTARABINE N N 220028868 CYTARABINE